Results 31 to 40 of about 167,569 (309)

A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.

open access: yesNew England Journal of Medicine, 2003
BACKGROUND For the treatment of myocardial infarction with ST-segment elevation, primary angioplasty is considered superior to fibrinolysis for patients who are admitted to hospitals with angioplasty facilities.
H. Andersen   +17 more
semanticscholar   +1 more source

Randomized trial of preventive angioplasty in myocardial infarction.

open access: yesNew England Journal of Medicine, 2013
BACKGROUND In acute ST-segment elevation myocardial infarction (STEMI), the use of percutaneous coronary intervention (PCI) to treat the artery responsible for the infarct (infarct, or culprit, artery) improves prognosis.
D. Wald   +7 more
semanticscholar   +1 more source

Target Balloon-Assisted Antegrade and Retrograde Approach for Recanalization of Thrombosed Fem-Pop Bypass Graft Using the Outback Catheter

open access: yes대한영상의학회지, 2016
The subintimal arterial flossing with antegrade-retrograde intervention (SAFARI) technique is reportedly effective in severe peripheral vascular disease that cannot be treated with standard endovascular techniques including subintimal angioplasty.
Jungwon Kwak   +4 more
doaj   +1 more source

Usefulness of Drug Eluting Stent in Percutaneous Coronary Intervention—A Single Center Experience in Taiwan

open access: yesJournal of the Formosan Medical Association, 2007
Drug eluting stents (DES) have been shown to reduce in-stent restenosis rate and target vessel revascularization in large clinical trials. However, the safety and efficacy of DES use in the Taiwanese population has not been reported.
Juey-Jen Hwang   +13 more
doaj   +1 more source

The Proliferation REduction with Vascular ENergy Trial (PREVENT)

open access: yesCurrent Controlled Trials in Cardiovascular Medicine, 2001
PREVENT was the first prospective, randomized placebo-controlled study of intracoronary beta radiotherapy with 32P. A total of 105 patients with de novo or restenotic lesions, treated by stenting or balloon angioplasty, received 0 (control), 16, 20, or ...
Kaluza Grzegorz L, Raizner Albert E
doaj   +1 more source

Distal Balloon Angioplasty of Cerebral Vasospasm Decreases the Risk of Delayed Cerebral Infarction

open access: yesAmerican Journal of Neuroradiology, 2019
A group of 392 patients was analyzed (160 before versus 232 after January 2015). Distal balloon angioplasty was associated with the following: higher rates of angioplasty (43% versus 27%) and intravenous milrinone (31% versus 9%); lower rates of ...
M. Labeyrie   +8 more
semanticscholar   +1 more source

Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.

open access: yesNew England Journal of Medicine, 2002
BACKGROUND As compared with thrombolytic therapy, primary percutaneous transluminal coronary angioplasty (PTCA) in acute myocardial infarction reduces the rates of death, reinfarction, and stroke, but recurrent ischemia, restenosis, and reocclusion of ...
G. Stone   +11 more
semanticscholar   +1 more source

Bilateral Transverse Sinus Angioplasty for the Treatment of Idiopathic Intracranial Hypertension – Case Report and Literature Review

open access: yesBrazilian Neurosurgery, 2019
Idiopathic intracranial hypertension (IIH) is a disease characterized by an increase in intracranial pressure, without presence of parenchymal lesions or hydrocephalus that justify it.
Luciano B. Manzato   +5 more
doaj   +1 more source

A comparative analysis of primary stenting and optimal balloon coronary angioplasty in acute myocardial infarction. Six month results from the STENT PAMI trial

open access: yesArquivos Brasileiros de Cardiologia, 2000
OBJECTIVE: To compare the outcome of balloon PTCA with final coronary stenosis diameter (SD)
Luiz Alberto Mattos   +9 more
doaj   +1 more source

Bioengineering Strategies for Treating Neointimal Hyperplasia in Peripheral Vasculature: Innovations and Challenges

open access: yesAdvanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
This review highlights emerging bioengineering strategies for treating neointimal hyperplasia in the peripheral vasculature, focusing on approaches that promote re‐endothelialization, modulate smooth muscle cell phenotype, reduce inflammation, mitigate oxidative stress, and optimize biomechanical compliance.
Nikita Wilson John   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy